Investor Pivotal bioVenture Partners Fund I, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Pivotal bioVenture Partners Fund I, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-27 13D/A INZY / Inozyme Pharma, Inc. 4,494,851 0
2024-12-09 13G OCS / Oculis Holding AG 2,032,296 2,174,074
2024-11-07 13G/A OCS / Oculis Holding AG 2,414,972 2,032,296
2024-02-12 13D/A BOLT / Bolt Biotherapeutics, Inc. 3,058,419 3,058,419
2024-02-12 13D/A RLYB / Rallybio Corporation 2,271,311 2,404,644
2024-02-12 13D/A INZY / Inozyme Pharma, Inc. 4,494,851 4,494,851
2024-02-12 13G/A OCS / Oculis Holding AG 3,032,296 2,414,972
2023-08-08 13D/A INZY / Inozyme Pharma, Inc. 3,661,518 4,494,851
2023-05-23 13D/A INZY / Inozyme Pharma, Inc. 3,213,586 3,661,518
2023-04-04 13D/A INZY / Inozyme Pharma, Inc. 2,661,154 3,213,586
2023-03-15 13G OCS / Oculis Holding AG 3,032,296
2022-08-25 13G/A AKUS / Akouos Inc 1,794,088 1,794,088
2022-04-28 13D INZY / Inozyme Pharma, Inc. 1,591,154 2,661,154
2022-02-14 13G/A INZY / Inozyme Pharma, Inc. 1,591,154 1,591,154
2022-02-14 13G/A AKUS / Akouos Inc 1,794,088 1,794,088
2021-08-13 13D/A BOLT / Bolt Biotherapeutics, Inc. 3,058,419
2021-08-12 13D RLYB / Rallybio Corporation 2,271,311
2021-02-09 13G INZY / Inozyme Pharma, Inc. 1,591,154 1,591,154
2021-02-09 13G AKUS / Akouos Inc 1,794,088 1,794,088
2021-02-09 13G/A ITRM / Iterum Therapeutics plc 945,086 945,085
2020-08-04 13D INZY / Inozyme Pharma, Inc. 1,591,154
2020-07-10 13D AKUS / Akouos Inc 1,794,088
2018-12-24 13D ETTX / Entasis Therapeutics Holdings Inc 1,180,178 1,180,178
2018-12-24 13G ITRM / Iterum Therapeutics plc 945,086 945,086
2018-12-22 13D ETTX / Entasis Therapeutics Holdings Inc 1,180,178
2018-12-22 13G ITRM / Iterum Therapeutics plc 945,086